Lucid Diagnostics Inc. Capital Expenditures
Lucid Diagnostics Inc. (LUCD) reported Capital Expenditures of $236.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-12
- Lucid Diagnostics Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $21.00K, a 16.00% decline year-over-year.
- Lucid Diagnostics Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $215.00K, a 131.18% increase year-over-year.
- Lucid Diagnostics Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-06-30 was $25.00K.
- Lucid Diagnostics Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-03-31 was $93.00K.
- Lucid Diagnostics Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $197.00K, a 33.45% decline from fiscal 2024.
- Lucid Diagnostics Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $296.00K.
- Lucid Diagnostics Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $3.20M, a 271.23% increase from fiscal 2021.
- Lucid Diagnostics Inc. payments to acquire property, plant, and equipment for fiscal 2021 was $862.00K.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 6 month as first filed | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 9 month as first filed | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $236.00K 10-Q · filed 2026-08-12 | ||||
| 2026-03-31 | $215.00K 10-Q · filed 2026-05-13 | |||||
| 2025-12-31 | $197.00K 10-K · filed 2026-03-25 | |||||
| 2025-06-30 | $25.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $118.00K 10-Q · filed 2026-08-12 | ||||
| 2025-03-31 | $93.00K 10-Q · filed 2026-05-13 | |||||
| 2024-12-31 | $296.00K 10-K · filed 2026-03-25 | |||||
| 2023-03-31 | $17.00K 10-Q · filed 2023-05-15 | $17.00K derived: sum of 2 quarters · filed 2024-03-25 | $1.02M derived: sum of 3 quarters · filed 2024-03-25 | $3.07M derived: sum of 4 quarters · filed 2024-03-25 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $1.00M derived: sum of 2 quarters · filed 2024-03-25 | $3.05M derived: sum of 3 quarters · filed 2024-03-25 | $3.20M 10-K · filed 2024-03-25 | ||
| 2022-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $3.05M derived: sum of 2 quarters · filed 2023-11-13 | $3.20M 10-Q · filed 2023-11-13 | $705.00K 10-Q · filed 2022-11-14 | $4.02M derived: sum of 4 quarters · filed 2023-11-13 | |
| 2022-06-30 | $2.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $2.20M 10-Q · filed 2023-08-14 | $384.00K 10-Q · filed 2022-08-15 | $3.02M derived: sum of 3 quarters · filed 2023-08-14 | $3.05M derived: sum of 4 quarters · filed 2023-08-14 | |
| 2022-03-31 | $148.00K 10-Q · filed 2023-05-15 | $972.00K derived: sum of 2 quarters · filed 2023-05-15 | $1.00M derived: sum of 3 quarters · filed 2023-05-15 | $1.00M derived: sum of 4 quarters · filed 2023-05-15 | ||
| 2021-12-31 | $824.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-06 | $852.00K derived: sum of 2 quarters · filed 2022-11-14 | $853.00K derived: sum of 3 quarters · filed 2022-11-14 | $862.00K 10-K · filed 2022-04-06 | ||
| 2021-09-30 | $28.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $29.00K derived: sum of 2 quarters · filed 2022-11-14 | $38.00K 10-Q · filed 2022-11-14 | $37.89K 10-Q · filed 2021-11-23 | ||
| 2021-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $10.00K 10-Q · filed 2022-08-15 | ||||
| 2021-03-31 | $9.00K 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |